News & Press

Abbisko is going to disclose two pre-clinical research results at the 35th EORTC-NCI-AACR Conference

Sep 20,2023
By Abbisko
Back

Abstract title: Discovery and characterization of an MTA-cooperative and brain-penetrant PRMT5 inhibitor

Poster number: C130

Session: Poster Session C                              

Session date and time: Saturday, October 14 | 12:30 pm-4:00 pm

Session location: Level 2, Exhibit Hall D

Abstract title: Discovery and characterization of a novel small molecule brain penetrant PD-L1 inhibitor

Poster number: B151

Session: Poster Session B                              

Session date and time: Friday, October 13 | 12:30 pm-4:00 pm

Session location: Level 2, Exhibit Hall D


Tel:(+86) 021-68912098

E-Mail:Bd@abbisko.com
    PR@abbisko.com
    IR@abbisko.com

Copyright © 2021 All rights reserved:Abbisko Therapeautics     沪ICP备17056565号-1    沪公网安备31011502401700    PRIVACY POLICY